Safety, Tolerability, and Systemic Exposure of Apo-Si- K170A-C76 in Healthy Volunteers

Clinical trial NCT07095049 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07095049
Sponsor: Interna Therapeutics Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

SARS-CoV-2 (COVID-19) Infection

Start date: 2024-09-04
Primary completion: 2025-07-14
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.